Abstract

In the original Article, Tables two and three had formatting issues which affected their clarity. This has been corrected in the PDF and HTML versions of this Article.

Details

Title
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
Author
Kasper Recourt 1 ; de Boer, Peter 2 ; Zuiker, Rob 3   VIAFID ORCID Logo  ; Luthringer, Remy 4 ; Kent, Justine 5 ; van der Ark, Peter 2 ; Ilse Van Hove 2 ; Joop van Gerven 1 ; Jacobs, Gabriel 1 ; Luc van Nueten 2 ; Drevets, Wayne 2 

1  Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands 
2  Janssen Research and Development, Division of Janssen Pharmaceutica N.V., Beerse, Belgium 
3  Centre for Human Drug Research, Leiden, The Netherlands 
4  Minerva Neurosciences, Waltham, MA, USA 
5  Sunovion, Fort Lee, NJ, USA 
Pages
1-1
Publication year
2019
Publication date
Oct 2019
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1038/s41398-019-0585-4
ProQuest document ID
2300157894
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.